Abstract
Malfunction in ion channels, due to mutations in genes encoding channel proteins or the presence of autoantibodies, are increasing being implicated in causing disease conditions, termed channelopathies. Dysfunction of potassium (K+) channels has been associated with the pathophysiology of a number of neurological, as well as peripheral, disorders (e.g., episodic ataxia, epilepsy, neuromyotonia, Parkinson’s disease, congenital deafness, long QT syndrome). K+ channels, which demonstrate a high degree of diversity and ubiquity, are fundamental in the control of membrane depolarisation and cell excitability. A common feature of K+ channelopathies is a reduction or loss of membrane potential repolarisation. The identification of K+ channel subtype specific openers will allow the recovery of the mechanism(s) responsible for counteraction of uncontrolled cellular depolarisation. Synthetic agents that demonstrate K+ channel opening properties are available for a variety of K+ channel subtypes (e.g., KATP, BKCa, G...

This publication has 61 references indexed in Scilit: